Based on previous publications in prostate cancer using an earlier analogue, F-4 [18], we chose to focus on the characterization of KU174 in the PC3-MM2 and LNCaP-LN3 cell-lines to further understand its mechanism of action and effects on Hsp90. Here, HSP90AB1 is linked to prostate carcinoma.